GlassScriptPhysician profile
Mark James Maguire
NPI 1295848422
$2,638.41
in general payments reported to CMS, 2019-2025
21 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $212 · 2021: $304 · 2022: $147 · 2023: $79.31 · 2024: $67.24 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729 · Travel and Lodging: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.18 |
| Travel and Lodging | $619.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $840.74 | 2025 | Iovera, Zilretta |
| Smith+Nephew, INC. | $651.10 | 2019-2023 | Collagenase Santyl |
| Bioventus LLC | $198.10 | 2025 | Xcell, Durolane, Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $155.21 | 2019 | |
| Pacira Therapeutics, INC. | $125.00 | 2019 | |
| Amgen INC. | $118.07 | 2025 | Evenity |
| Medtronic USA, INC. | $84.80 | 2019 | |
| Stryker Corporation | $76.25 | 2019-2021 | |
| Zyla Life Sciences, INC. | $52.48 | 2019 | |
| Next Science LLC | $51.05 | 2022 | |
| Pylant Medical | $44.72 | 2021-2022 | |
| Polynovo North America LLC | $42.38 | 2024 | Novosorb Btm |
| Kowa Pharmaceuticals America, INC. | $37.78 | 2023 | Seglentis |
| Heron Therapeutics, INC. | $25.05 | 2025 | Zynrelef |
| Orthalign INC | $24.86 | 2024 | Orthalign Plus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.09 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.47 | 2025 | |
| Paratek Pharmaceuticals, INC. | $19.93 | 2021 | |
| Innovation Technologies INC | $18.90 | 2021 | |
| Horizon Therapeutics Plc | $14.42 | 2023 | Krystexxa |
| Convatec INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Maguire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.